E. Zelenskaya

Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction.

It is suggested that an ML framework incorporating CYP2C19 genotype can stratify long-term MACE risk and supports the potential role of ticagrelor, particularly in genetically defined high-risk MI patients, for optimizing secondary prevention.